Login
$CYTK
$52.61 -$0.56 (1.05%) After hours

$CYTK 8-K/A SEC Filings

Filed On Filing
08 Sep 2025 8-K/A: Other Events

Improves Cardiac Structure and Function Compared to Metoprolol;

19 Jul 2021 8-K/A: Other Events

On July 19, 2021 Cytokinetics, Incorporated (the “Registrant” or “Cytokinetics”) announced positive topline results from Cohorts 1 and 2 of REDWOOD-HCM (Randomized Evaluation of Dosing With CK-274 in Obstructive Outflow Disease in HCM), ...

28 Jun 2012 8-K/A: Amendments to Articles/Bylaws; Change in Fiscal Year

On June 22, 2012, pursuant to the two underwriting agreements (each, an “Underwriting Agreement”) with Cowen and Company LLC (“Cowen”) as representative of the several underwriters named therein (the “Underwriters”), each dated June 20, ...

09 Sep 2011 8-K/A: Submission of Matters to a Vote of Security Holders

Explanatory Note On May 20, 2011, Cytokinetics, Inc. (the "Company") filed a Current Report on Form 8-K (the "Original 8-K") reporting the voting results from its 2011 Annual Meeting of Stockholders that was held on May 18, 2011. The sol...

20 Apr 2011 8-K/A: Amendments to Articles/Bylaws; Change in Fiscal Year

On April 18, 2011, pursuant to the Securities Purchase Agreement entered into between Cytokinetics, Incorporated (the "Company") and Deerfield Private Design Fund II, L.P., Deerfield Private Design International II, L.P., Deerfield Speci...

19 Feb 2009 8-K/A: Departure/Election of Directors or Officers; Compensation

South San Francisco, CA, February 19, 2009 – Cytokinetics, Incorporated (Nasdaq: CYTK) announced today that Dr. John T. Henderson has been appointed to the company’s Board of Directors.

20 Jun 2008 8-K/A: Entry into a Material Definitive Agreement

Scott R. Jordan (Media) Director, Corporate Development (650) 624-3000

13 Dec 2005 8-K/A: Entry into a Material Definitive Agreement; Creation of a Direct Financial Obligation

This Sublease (“Sublease”), dated November 23rd, 2005 for reference purposes only, is entered into by and between Millennium Pharmaceuticals, Inc. a Delaware corporation (“Sublandlord”), and Cytokinetics, Incorporated, a Delaware corpora...

19 Oct 2005 8-K/A: Departure/Election of Directors or Officers; Compensation

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support